title: Transrectal ultrasound-guided transperineal and transrectal management of seminal vesicle abscesses.
abstract: OBJECTIVE
  The treatment of seminal vesicle abscesses (SVA) by transrectal ultrasound-guided transrectal and transperineal approaches were evaluated in this study.
  
  
  METHODS
  Six SVA cases were diagnosed among 2350 patients admitted to our ultrasound unit with prostate and seminal vesicle symptoms during the last 6 years. Four out of six cases had bilateral, and two had unilateral SVA. Transperineal puncture and aspiration was done in four patients with bilateral abscesses and transrectal approach was preferred in two patients with unilateral abscesses.
  
  
  RESULTS
  For both approaches, the aspiration was successfully done without any complication. The mean durations of intervention were 64 and 13 min, and the durations of hospitalization were 2 and 3 days for the transperineal and transrectal approaches, respectively.
  
  
  CONCLUSIONS
  Transrectal ultrasound examination allows simultaneous evaluation of the gland and the guidance for a needle puncture and aspiration. Furthermore, rapid pain relief, regression of other symptoms, minimally invasive technique and shorter hospitalization seem to be important features as compared with conservative and surgical treatment modalities.
authors.affiliation: Department of Radiology, Gülhane Military Medical Academy, 06018 Etlik-Ankara, Turkey. mdsaglam@yahoo.com
authors.forename: Mutlu
authors.initials: M
authors.lastname: Sağlam
authors.forename: Sahin
authors.initials: S
authors.lastname: Uğurel
authors.forename: Mete
authors.initials: M
authors.lastname: Kilciler
authors.forename: Mustafa
authors.initials: M
authors.lastname: Taşar
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Somuncu
authors.forename: Taner
authors.initials: T
authors.lastname: Uçöz
mesh_terms: D000038:Abscess / Q000000981:diagnostic imaging / Q000601:surgery*; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002440:Cefoxitin / Q000627:therapeutic use; D004927:Escherichia coli Infections / Q000000981:diagnostic imaging / Q000601:surgery; D005500:Follow-Up Studies; D005832:Genital Diseases, Male / Q000000981:diagnostic imaging / Q000601:surgery*; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D019060:Minimally Invasive Surgical Procedures; D009339:Needles; D019152:Paracentesis / Q000295:instrumentation; D010502:Perineum; D012007:Rectum; D012669:Seminal Vesicles / Q000000981:diagnostic imaging / Q000601:surgery*; D013396:Suction / Q000295:instrumentation; D013997:Time Factors; D018084:Ultrasonography, Interventional
chemical_list: D000900:Anti-Bacterial Agents; D002440:Cefoxitin